Cleared Traditional

K983804 - THE APTUS (AUTOMATED) APPLICATION OF THE EBV-EA IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR (FDA 510(k) Clearance)

Dec 1998
Decision
41d
Days
Class 1
Risk

K983804 is an FDA 510(k) clearance for the THE APTUS (AUTOMATED) APPLICATION OF THE EBV-EA IGG ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR. This device is classified as a Epstein-barr Virus, Other (Class I - General Controls, product code LSE).

Submitted by Zeus Scientific, Inc. (Raritan, US). The FDA issued a Cleared decision on December 8, 1998, 41 days after receiving the submission on October 28, 1998.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3235.

Submission Details

510(k) Number K983804 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 28, 1998
Decision Date December 08, 1998
Days to Decision 41 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement

Device Classification

Product Code LSE — Epstein-barr Virus, Other
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3235